Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $550.70 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SI-BONE, Inc. | $145.34 | 1 | $0 (2022) |
| Smith+Nephew, Inc. | $124.07 | 2 | $0 (2021) |
| DePuy Synthes Sales Inc. | $115.26 | 1 | $0 (2022) |
| Stryker Corporation | $70.92 | 1 | $0 (2023) |
| Novo Nordisk Inc | $26.05 | 2 | $0 (2021) |
| Amgen Inc. | $23.18 | 1 | $0 (2021) |
| Amarin Pharma Inc. | $17.13 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.13 | 1 | $0 (2023) |
| Dexcom, Inc. | $13.62 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $86.05 | 2 | Stryker Corporation ($70.92) |
| 2022 | $274.22 | 3 | SI-BONE, Inc. ($145.34) |
| 2021 | $190.43 | 6 | Smith+Nephew, Inc. ($124.07) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2023 | Stryker Corporation | INSPACE (Device) | Food and Beverage | In-kind items and services | $70.92 | General |
| Category: SPORTS MEDICINE | ||||||
| 08/04/2022 | DePuy Synthes Sales Inc. | DYNACORD (Device) | Food and Beverage | In-kind items and services | $115.26 | General |
| Category: Sports_Surgical | ||||||
| 07/08/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Endocrinology | ||||||
| 06/22/2022 | SI-BONE, Inc. | — | Food and Beverage | Cash or cash equivalent | $145.34 | General |
| 09/14/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiovascular | ||||||
| 06/16/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 04/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Diabetes | ||||||
| 04/07/2021 | Smith+Nephew, Inc. | REGENETEN (Device), WEREWOLF | Food and Beverage | In-kind items and services | $117.10 | General |
| Category: Extremities & Limb Restoration | ||||||
| 01/22/2021 | Smith+Nephew, Inc. | DYONICS PLATINUM (Device) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: Sports Med Resection | ||||||
| 01/05/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 831 | 5,168 | $286,678 | $79,360 |
| 2022 | 11 | 773 | 22,207 | $288,390 | $100,699 |
| 2021 | 8 | 691 | 25,198 | $239,080 | $99,474 |
| 2020 | 10 | 591 | 26,403 | $200,798 | $79,533 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2023 | 35 | 3,180 | $92,220 | $16,345 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 202 | $37,168 | $15,022 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 290 | $37,410 | $14,927 | 39.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 183 | 347 | $70,784 | $14,196 | 20.1% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2023 | 13 | 672 | $22,176 | $8,934 | 40.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 76 | 76 | $12,920 | $4,366 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $7,020 | $2,696 | 38.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 158 | 332 | $6,308 | $2,680 | 42.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 27 | 42 | $672.00 | $194.46 | 28.9% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2022 | 33 | 2,580 | $74,820 | $26,397 | 35.3% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2022 | 28 | 18,312 | $54,936 | $25,118 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 166 | 287 | $37,023 | $15,561 | 42.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 167 | 363 | $71,890 | $15,516 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 129 | $23,736 | $8,994 | 37.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 84 | 84 | $14,280 | $4,763 | 33.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 137 | 276 | $5,244 | $2,236 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $4,420 | $1,452 | 32.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 22 | 70 | $1,120 | $358.01 | 32.0% |
| Q4014 | Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass | Office | 2022 | 12 | 13 | $845.00 | $298.44 | 35.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 14 | 76 | $76.00 | $6.43 | 8.5% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2021 | 37 | 23,353 | $70,560 | $40,819 | 57.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 183 | 378 | $45,532 | $20,438 | 44.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 159 | 343 | $68,730 | $15,130 | 22.0% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2021 | 12 | 640 | $21,120 | $9,083 | 43.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 85 | 85 | $14,326 | $5,791 | 40.4% |
About Meghan Harms
Meghan Harms is a Physician Assistant healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2012. The National Provider Identifier (NPI) number assigned to this provider is 1982949764.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Meghan Harms has received a total of $550.70 in payments from pharmaceutical and medical device companies, with $86.05 received in 2023. These payments were reported across 11 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($550.70).
As a Medicare-enrolled provider, Harms has provided services to 2,886 Medicare beneficiaries, totaling 78,976 services with total Medicare billing of $359,066. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Oklahoma City, OK
- Active Since 12/04/2012
- Last Updated 12/04/2012
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1982949764
Products in Payments
- REGENETEN (Device) $117.10
- DYNACORD (Device) $115.26
- INSPACE (Device) $70.92
- Ozempic (Drug) $26.05
- Aimovig (Biological) $23.18
- Vascepa (Drug) $17.13
- TRINTELLIX (Drug) $15.13
- Dexcom G6 Transmitter (Medical Supply) $13.62
- DYONICS PLATINUM (Device) $6.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Oklahoma City
Jennifer Smith, Pa, PA
Physician Assistant — Payments: $74,736
Sarah Hawk, Pa, PA
Physician Assistant — Payments: $21,842
Gavin Christie, Pa, PA
Physician Assistant — Payments: $18,388
Brett Horst, Pa, PA
Physician Assistant — Payments: $13,890
Ms. Mary Jane Rorick, Pa-C, PA-C
Physician Assistant — Payments: $13,494
Jovonne Smith, Pa, PA
Physician Assistant — Payments: $11,871